Fish Skin Disease Market, By Type (Ichthyosis vulgaris, X-linked recessive ichthyosis, Others (Autosomal recessive congenital ichthyosis, etc.)), By Treatment type (Corticosteroids, Emollients, Retinoids, Others (Keratolytics, etc.)), By Route of Administ

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	160 Pages	Coherent Market Insights	October, 2023	CMI18366457

Best Price Guarantee
Price	from $4,500
Length	160 Pages
Publisher	Coherent Market Insights
Published Date	October, 2023
SKU	CMI18366457

Fish Skin Disease Market, By Type (Ichthyosis vulgaris, X-linked recessive ichthyosis, Others (Autosomal recessive congenital ichthyosis, etc.)), By Treatment type (Corticosteroids, Emollients, Retinoids, Others (Keratolytics, etc.)), By Route of Administration (Topical, Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Ichthyosis is a medical condition that causes widespread and persistent thick, dry, "fish-scale" skin. It is a group of skin disorders that lead to dry and itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but some forms of the disease can affect internal organs as well. There are more than 20 different types of ichthyosis. Some types are inherited at birth, and others are acquired during adulthood. The treatment helps reduce the redness of the skin, thickness of the scales, and itching.

Market Dynamics:

The rise in burden of fish skin disease, the rise in awareness among people, the increase in demand for safe, effective treatments & therapies, and the introduction of novel treatments and therapies by market players are major factors expected to propel growth of the global fish skin disease market.

For instance, in April 2023, Kerecis, a manufacturer of fish skin-based therapeutic products announced the launch of the MariGen Shield, a solution that combines the company’s fish-skin graft and a silicone contact layer to treat chronic and complex wounds. The silicone contact layer anchors the round graft in position and help safeguard granulating wound

Moreover, in October 2021, Kerecis received the U.S. Food and Drug Administration (FDA) marketing authorization for Omega3 SurgiBind. It is an implantable fish-skin graft intended for use in plastic and reconstructive surgery. It is indicated for strengthening weak soft tissue in patients who require soft tissue repair or reinforcement in plastic or reconstructive surgery.

Key features of the study:

This report provides in-depth analysis of the global fish skin disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–20230), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fish skin disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK Plc., AbbVie Inc., Sonnet BioTherapeutics, Krystal Biotech, LEO Pharma, GALDERMA, GLENMARK PHARMACEUTICALS LTD., Mayne Pharma Group Limited, Ortho Dermatologics, Cellegy Pharmaceuticals, Patagonia Pharmaceuticals, LLC, Crown Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global fish skin disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish skin disease market

Fish Skin Disease Market Detailed Segmentation:

By Type:
Ichthyosis vulgaris
X-linked recessive ichthyosis
Others (Autosomal recessive congenital ichthyosis, etc.)
By Treatment Type:
Corticosteroids
Emollients
Retinoids
Others (Keratolytics, etc.)
By Route of Administration:
Topical
Oral
Parenteral
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles:
GSK Plc.
AbbVie Inc.
Sonnet BioTherapeutics
Krystal Biotech
LEO Pharma
GALDERMA
GLENMARK PHARMACEUTICALS LTD.
Mayne Pharma Group Limited
Ortho Dermatologics
Cellegy Pharmaceuticals
Patagonia Pharmaceuticals, LLC
Crown Laboratories, Inc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Fish Skin Disease, By Type; Market Fish Skin Disease, By Treatment Type; Market Fish Skin Disease, By Route of Administration; Market Fish Skin Disease, By Distribution Channel; Market Fish Skin Disease, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Rise in burden of fish skin disease across the globe; Lack of awareness among people; Increase in demand for safe and effective treatments/therapies; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Fish Skin Disease Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Fish Skin Disease Market, By Type, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019-2030; Segment Trends; Ichthyosis vulgaris; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030,(US$ Bn); X-linked recessive ichthyosis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030,(US$ Bn); Others (Autosomal recessive congenital ichthyosis, etc.); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030,(US$ Bn)
6. Fish Skin Disease Market, By Treatment Type, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 - 2030; Segment Trends; Corticosteroids; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030,(US$ Bn); Emollients; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030,(US$ Bn); Retinoids; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030,(US$ Bn); Others (Keratolytics, etc.); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030,(US$ Bn)
7. Fish Skin Disease Market, By Route of Administration, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 - 2030; Segment Trends; Topical; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Oral; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Parenteral; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
8. Fish Skin Disease Market, By Distribution Channel, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 - 2030; Segment Trends; Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
9. Fish Skin Disease Market, By Region, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019 - 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn); Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn); U.S.; Canada; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Bn); Germany; U.K.; Spain; France; Italy; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Bn); India; China; Japan; Australia; ASEAN; South Korea; Rest of Asia Pacific; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Bn); Brazil; Argentina; Mexico; Rest of Latin America; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Bn); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Bn); North Africa; Central Africa; South Africa
10. Competitive Landscape: GSK Plc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; AbbVie Inc.; Sonnet BioTherapeutics; Krystal Biotech; LEO Pharma; GALDERMA; GLENMARK PHARMACEUTICALS LTD.; Mayne Pharma Group Limited; Ortho Dermatologics; Cellegy Pharmaceuticals; Patagonia Pharmaceuticals, LLC; Crown Laboratories, Inc.; Analyst Views
11. Section: Research Methodology; About us; *Browse 44 market data tables and 37 figures on "Global Fish Skin Disease Market” - forecast to 2030